πŸ₯ MS-DRG System: Complete Overview β€” FY 2025

MS-DRG System: Complete Overview

Medicare Severity Diagnosis Related Groups β€” FY 2025 (v42.0)

Executive Summary

The Medicare Severity Diagnosis Related Group (MS-DRG) system is the classification methodology used by CMS to determine payment for inpatient hospital services under the Inpatient Prospective Payment System (IPPS).
β€’ Total MS-DRGs in v42.0: 775 [1]
β€’ Payment basis: Fixed rate per discharge, adjusted for severity (CC/MCC), geography, and hospital characteristics
β€’ Core logic: Principal diagnosis β†’ MDC β†’ Surgical/Medical branch β†’ CC/MCC stratification β†’ Final DRG
β€’ Effective: October 1, 2024 - September 30, 2025 [2]


πŸ“š Historical Context: From DRG to MS-DRG

Evolution Timeline

timeline
    title MS-DRG System Evolution
    section Pre-1983
        Fee-for-Service : Hospitals paid per service<br>no cost containment
    section 1983
        DRG System Launched : 467 DRGs<br>no severity adjustment
    section 2007
        MS-DRG Implemented : Severity stratification added<br>CC/MCC logic refined
    section 2024-2025
        v42.0 Updates : 775 DRGs<br>4 new MCC codes<br>29 new CC codes

Why MS-DRG Replaced Original DRGs

Issue with Original DRGsMS-DRG Solution
No distinction between mild and severe casesStratifies each DRG into: with MCC, with CC, without CC/MCC
Underpayment for complex patientsHigher payment weights for MCCs reflect resource intensity
Overpayment for simple casesLower weights for β€œwithout CC/MCC” prevent windfalls
Limited clinical granularityExpanded code set (74,044 ICD-10-CM codes in FY2025) 49

Key Concept

MS-DRG = Medicare Severity. The β€œMS” prefix denotes that payment is adjusted for patient severity via CC/MCC designationβ€”not just the principal diagnosis.


πŸ”‘ Core Components of the MS-DRG System

1. MDC (Major Diagnostic Category) Framework

25 Major Diagnostic Categories (MDCs) organize DRGs by body system or condition type:

PRE-MDC (001-019)  : Tracheostomy, ECMO, transplant, multiple significant trauma
MDC 01 (020-042)   : Nervous System
MDC 02 (113-125)   : Eye Disorders
MDC 03 (126-159)   : Ear, Nose, Mouth & Throat
MDC 04 (163-208)   : Respiratory System
MDC 05 (209-317)   : Circulatory System
MDC 06 (326-446)   : Digestive System
MDC 07 (447-456)   : Hepatobiliary System & Pancreas
MDC 08 (457-516)   : Musculoskeletal System & Connective Tissue
MDC 09 (517-535)   : Skin, Subcutaneous Tissue & Breast
MDC 10 (536-643)   : Endocrine, Nutritional & Metabolic
MDC 11 (650-707)   : Kidney & Urinary Tract
MDC 12 (708-714)   : Male Reproductive System
MDC 13 (715-761)   : Female Reproductive System
MDC 14 (765-800)   : Pregnancy, Childbirth & Puerperium
MDC 15 (789-799)   : Newborns & Other Neonates
MDC 16 (800-808)   : Blood, Blood Forming Organs & Immunologic Disorders
MDC 17 (809-829)   : Myeloproliferative Diseases & Poorly Differentiated Neoplasms
MDC 18 (830-849)   : Infectious & Parasitic Diseases
MDC 19 (870-887)   : Mental Diseases & Disorders
MDC 20 (888-897)   : Alcohol/Drug Use or Induced Mental Disorders
MDC 21 (898-909)   : Injuries, Poisonings & Toxic Effects of Drugs
MDC 22 (910-923)   : Burns
MDC 23 (927-947)   : Factors Influencing Health Status (Z codes)
MDC 24 (948-951)   : Multiple Significant Trauma
MDC 25 (955-959)   : HIV Infections

2. CC/MCC Severity Stratification

Each MS-DRG may have up to 3 severity levels:

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚ DRG XXX: [Procedure/Condition]  β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ XXX-A: WITH MCC  ← Highest payment weight β”‚
β”‚ XXX-B: WITH CC   ← Moderate payment weight β”‚
β”‚ XXX-C: WITHOUT CC/MCC ← Base payment weight β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

β€’ MCC = Major Complication/Comorbidity (end-of-life, organ failure, ICU-level care)
β€’ CC = Complication/Comorbidity (chronic illness exacerbation, post-procedure impact)
β€’ Non-CC = Conditions not meeting severity criteria or not POA

Critical Rule

A secondary diagnosis qualifies as CC/MCC only if:

  1. It is documented by the provider as a diagnosis (not just a symptom)
  2. It affects patient care (evaluation, treatment, diagnostics, LOS, nursing)
  3. It is present on admission (POA=Y) OR, if POA=N, is not on the HAC exclusion list 6

3. Grouper Logic Workflow

graph TD
    A[Claim Input:<br>Principal Dx + Procedures + Secondary Dx] --> B{Pre-MDC Assignment?}
    B -->|Yes: Trach/ECMO/Transplant | C[Assign Pre-MDC DRG 001-019]
    B -->|No | D[Assign to MDC via Principal Dx Code]
    D --> E{ICD-10-PCS Procedure Present?}
    E -->|Yes + OR Procedure | F[Assign to Surgical DRG within MDC]
    E -->|Yes + Non-OR Procedure | G[May still affect DRG if 'significant']
    E -->|No | H[Assign to Medical DRG within MDC]
    F & G & H --> I{Any Secondary Dx = MCC?}
    I -->|Yes | J[Assign DRG with MCC suffix]
    I -->|No | K{Any Secondary Dx = CC?}
    K -->|Yes | L[Assign DRG with CC suffix]
    K -->|No | M[Assign DRG without CC/MCC]
    J & L & M --> N[Apply MCE Edits & POA Logic]
    N --> O[Final MS-DRG Output + Payment Weight]

πŸ’° Payment Calculation Methodology

Base Formula

Payment = [Base Rate Γ— DRG Weight Γ— Wage Index] + Adjustments

Where:
β€’ Base Rate FY2025: $6,785.92 (national operating standard) [[42]]
β€’ DRG Weight: Relative resource intensity (e.g., DRG 291 w/ MCC = 3.8421)
β€’ Wage Index: Geographic labor cost adjustment (varies by hospital CBSA)
β€’ Adjustments: DSH, IME, new technology add-on, outlier payments

Example Calculation: DRG 291 (Heart Failure with MCC)

Scenario: Urban teaching hospital in NYC (Wage Index = 1.3852)
 
Step 1: Base Payment
$6,785.92 Γ— 3.8421 (DRG weight) = $26,072.47
 
Step 2: Apply Wage Index
$26,072.47 Γ— 1.3852 = $36,115.58
 
Step 3: Add Adjustments
β€’ IME (Graduate Medical Education): +5.5% = +$1,986.36
β€’ DSH (Disproportionate Share): +8.2% = +$2,961.48
β€’ Outlier (if LOS > geometric mean): Variable
 
Step 4: Total Estimated Payment
β‰ˆ $41,063.42 + outlier (if applicable)
 
Compare to DRG 293 (Heart Failure WITHOUT CC/MCC):
Weight = 0.8795 β†’ Base payment β‰ˆ $9,380 before adjustments
β†’ MCC adds ~$31,683 in this example

Payment Impact Insight

Adding a single MCC can increase reimbursement by 20,000+ depending on the base DRG and hospital adjustments. This is why clinical validation and precise documentation are financially critical.


πŸ“‹ Key Terminology & Definitions

TermDefinitionCoding Implication
Principal DiagnosisCondition established after study as chiefly responsible for admission 6Must map to valid MDC; drives initial DRG branching
Other DiagnosesConditions coexisting at admission or developing subsequently that affect care 6Must meet clinical significance criteria to qualify as CC/MCC
CC (Complication/Comorbidity)Secondary diagnosis that increases LOS by β‰₯1 day or requires additional resources 24Moderate payment weight increase
MCC (Major CC)Secondary diagnosis representing organ failure, end-of-life, or ICU-level care 24Highest payment weight increase
POA (Present on Admission)Indicator (Y/N/U/W/1) denoting whether condition existed at inpatient admission 6POA=N + HAC list = no CC/MCC payment adjustment
HAC (Hospital-Acquired Condition)Preventable complication CMS will not pay extra for if POA=N 24Stage 3/4 pressure ulcers, CAUTI, post-op PE/DVT, etc.
OR vs. Non-OR ProcedureCMS designation determining if procedure drives surgical DRG assignment 1Only OR procedures typically trigger surgical DRG branching
MCE (Medicare Code Editor)Pre-grouper software that validates codes, POA, age/sex edits 1Claims failing MCE edits are rejected pre-payment
Geometric Mean LOSStatistical midpoint of length of stay for each DRG 1Used to calculate outlier payments for exceptionally long stays

πŸ”„ Practical Coding Workflow: Step-by-Step

Phase 1: Pre-Admission & Admission

βœ… Verify principal diagnosis reflects reason for admission after study
βœ… Document all comorbidities impacting care in H&P
βœ… Assign POA indicators at time of documentation (Y/N/U/W)
βœ… Query early if diagnosis lacks specificity (severity, laterality, relationship)

Phase 2: During Stay

βœ… Track new diagnoses/complications with clear POA=N documentation
βœ… Link complications to procedures when clinically appropriate
βœ… Document clinical criteria supporting CC/MCC designations:
   β€’ Labs/imaging for organ dysfunction
   β€’ Interventions requiring additional resources
   β€’ Extended monitoring or nursing care
βœ… Update problem list with active vs. historical status

Phase 3: Discharge & Coding

βœ… Sequence diagnoses per UHDDS guidelines:
   1. Principal diagnosis (reason for admission)
   2. Secondary diagnoses affecting care (CC/MCC candidates first)
βœ… Verify ICD-10-CM codes meet specificity requirements:
   β€’ Laterality digits (1=right, 2=left, 3=bilateral, 9=unspecified)
   β€’ 7th characters for injuries/procedures (A=initial, D=subsequent, S=sequela)
   β€’ Combination codes (e.g., diabetes + manifestation)
βœ… Run claim through MCE logic or encoder software
βœ… Confirm final MS-DRG aligns with clinical picture
βœ… Submit with all required POA indicators

Phase 4: Post-Submission

βœ… Monitor for RAC/MAC audits focusing on:
   β€’ Clinical validation of CC/MCC diagnoses
   β€’ POA accuracy for HAC-listed conditions
   β€’ Principal diagnosis sequencing appropriateness
βœ… Track query response rates and documentation improvement opportunities
βœ… Update internal coding guidelines based on audit feedback

Clinical Validation Query

Subject: Clinical Validation β€” [Condition] β€” [MRN]

Clinical Indicators:
β€’ [Relevant labs/imaging/assessments]
β€’ [Provider documentation excerpt]

Coding Guidance:
β€’ Per ICD-10-CM Official Guidelines Section I.B.19, code assignment requires provider diagnostic statement.
β€’ For [condition] to qualify as [CC/MCC], documentation must support [specific criteria].

Request:
☐ Is [condition] confirmed?
☐ If yes, is it [acute/chronic/severe/with organ dysfunction]?
☐ Is it present on admission (POA=Y) or developed during stay (POA=N)?
☐ Is it related to [other condition/procedure]?

Provider Response: _______________ Signature/Date: _______________

⚠️ Common Pitfalls & Best Practices

Top 10 Coding Errors in MS-DRG Assignment

ErrorConsequencePrevention Strategy
Unspecified principal diagnosisMCE rejection or downcoded DRGQuery for specificity before final coding
CC/MCC without clinical supportAudit recoupment + penaltiesApply the β€œNine Guiding Principles” for CC/MCC analysis 6
POA indicator errorsHAC payment denialsTrain clinicians to document β€œpresent on admission” explicitly
Sequencing secondary diagnoses incorrectlyMissed CC/MCC payment impactPlace qualifying CC/MCC diagnoses early in secondary list
Using outdated ICD-10-CM codesClaim rejectionUpdate encoder software annually; verify against CMS code tables
Ignoring MCE editsPre-payment rejectionRun all claims through MCE logic before submission
Coding ruled-out diagnoses as confirmedOverpayment riskOnly code uncertain diagnoses as confirmed for inpatient (per guidelines)
Missing laterality/stage specificityDowncoded to unspecifiedQuery providers using specialty-specific templates
Failing to link complications to proceduresMissed T80-T88 codesReview operative reports for post-procedural conditions
Overlooking combination codesUnbundling denialsUse ICD-10-CM Index to identify required combination codes

Best Practices Checklist

βœ… DOCUMENTATION
β€’ Ensure provider statements are specific: "acute systolic heart failure" not just "HF"
β€’ Link related conditions: "sepsis due to E. coli UTI" not separate diagnoses
β€’ Specify severity: "severe malnutrition," "stage 4 CKD," "moderate COPD exacerbation"
 
βœ… CODING
β€’ Always verify Tabular List after Alphabetic Index lookup
β€’ Apply Excludes1 notes correctly (mutually exclusive conditions)
β€’ Use combination codes when required (e.g., diabetes + manifestation)
 
βœ… COMPLIANCE
β€’ Query when documentation is ambiguousβ€”not for coder preference
β€’ Retain query responses in medical record for audit defense
β€’ Conduct internal audits focusing on high-dollar DRGs and HAC-prone conditions
 
βœ… EDUCATION
β€’ Train clinicians on documentation requirements for CC/MCC capture
β€’ Share DRG impact examples to illustrate financial/clinical alignment
β€’ Provide specialty-specific quick references (e.g., [[AAO ICD-10-CM for Ophthalmology]])

πŸ†• FY 2025 MS-DRG Updates (v42.0 Highlights)

New DRGs Created

DRGTitleMDCClinical Rationale
317Cardiac Defibrillator Implant with MCC or Carotid Sinus Neurostimulator05Recognize BAROSTIMβ„’ system cases
426-428Multiple Level Significant Trauma with MCC/CC/withoutPRE-MDCBetter stratify polytrauma resource use

DRGs Deleted

DRGTitleReason
453-455Combined Anterior/Posterior Spinal Fusion (all severities)Consolidated into revised spinal fusion DRGs

CC/MCC List Changes

+ ADDED TO MCC LIST (4 codes):
+ Selected poisoning codes with specific intent + complication
+ Sepsis codes with enhanced organ dysfunction specificity
 
+ ADDED TO CC LIST (29 codes):
+ Expanded CKD staging codes (N18.31-N18.33)
+ Additional malnutrition severity codes (E44.0 variants)
+ New respiratory failure subtypes (J96.01-J96.02)
+ Selected post-procedural complication codes
 
- DELETED/REVISED:
+ Codes merged into combination codes per ICD-10-CM updates
+ Obsolete terminology aligned with current clinical practice

Payment Rate Updates

β€’ National Operating Base Rate: $6,785.92 (+2.8% from FY2024)
β€’ Capital Base Rate: $475.93
β€’ Outlier Fixed Loss Threshold: $28,976 (increases outlier eligibility)
β€’ New Technology Add-On Payments: 75 applications approved for FY2025

FY2025 Action Item

Update encoder software and internal CC/MCC reference lists by September 15, 2024 to ensure seamless transition to v42.0 logic on October 1.


πŸ“š Official Resources & References

ResourceLinkPurpose
CMS MS-DRG Classifications Portalcms.gov/ms-drgDownload grouper software, DRG definitions, change logs
FY 2025 IPPS Final RuleFederal RegisterPolicy rationale, payment rate updates, regulatory changes
ICD-10-CM Code Tables FY 2025cms.gov/icd10mVerify code validity, descriptors, and instructional notes
CC/MCC Master Lists (Excel)CMS DownloadOfficial designation of every ICD-10-CM code as CC/MCC/Non-CC
Medicare Code Editor (MCE) SpecificationsCMS MCE PageUnderstand pre-grouper validation rules and edit logic
AHA Coding Clinic for ICD-10-CM/PCSahacentraloffice.orgOfficial coding advice for complex or ambiguous scenarios

πŸ“š Medical Coding Complications and Comorbidities for ENT, Ophthalmology, Urology, and PM&R

Medical SpecialtyProcedure or ConditionComplication/Comorbidity DescriptionICD-10-PCS or CPT CodeMedical Decision Making (MDM) LevelMorbidity/Mortality Risk FactorsManagement Strategy
Ear, Nose, and Throat (ENT)Endoscopic Endonasal Surgery of the Skull Base (EESSB)Extensive cavernous sinus invasion during skull base tumor resection.62165-22 or 31299HighTechnical difficulty; potential for prolonged impairment of bodily function.Intradural resection; dural repair; potential lumbar drain (62272).
Ear, Nose, and Throat (ENT)EpiglottitisPotential threat to life or bodily function.Not in sourceHighHigh risk of morbidity without treatment; threat to life.Extensive evaluation to identify or rule out highly morbid condition.
Ear, Nose, and Throat (ENT)Malignant otitis externaOsteomyelitis of the skull base; necrotizing infection.H60.20, H60.2HighHigh mortality risk in elderly or immunocompromised patients.Long-term systemic antibiotic drug therapy monitoring; debridement of necrotic tissue.
Ear, Nose, and Throat (ENT)Postprocedural infection/SepsisSepsis following a procedure; surgical site infection.T81.44HighSeptic shock; acute organ dysfunction.Identification of infectious agent (B95-B97); monitoring for acute organ dysfunction.
Ear, Nose, and Throat (ENT)Ventilator associated Pneumonia (VAP)Complication from mechanical ventilation in respiratory cases.J95.851HighRisk of respiratory failure (J96).Identify infectious organism (e.g., Pseudomonas B96.5); monitoring of ventilator dependence (Z99.12).
Ear, Nose, and Throat (ENT)Pediatric AdenotonsillectomySevere Obstructive Sleep Apnea (OSA), asthma, obesity.Not in sourceHighRespiratory depression; ultra-rapid metabolism of codeine (CYP2D6 genotype); post-op hypoxia.Avoidance of codeine; around-the-clock acetaminophen/ibuprofen; overnight monitoring.
Ear, Nose, and Throat (ENT)Trauma Consultation / Facial bone repairBroken orbital bones, skull bones; threat to life or bodily function.99223 or 99255HighMultiple acute injuries from major trauma.CT scans; emergency surgical planning; hospitalization.
Ear, Nose, and Throat (ENT)Acute mastoiditisSubperiosteal abscess; empyema of mastoid; intracranial extension.H70.09, H70.01, H70.093Moderate to HighRisk of meningitis, brain abscess, and hearing loss.Intravenous antimicrobial therapy; surgical drainage (mastoidectomy).
Ear, Nose, and Throat (ENT)Foreign body in nose or respiratory tractAsphyxiation; inflammation; obstruction.T17.0, T17.1Moderate to HighThreat to life or bodily function due to airway restriction.Removal of foreign body; diagnostic imaging (CT Head/Neck if trauma suspected).
Eye (Ophthalmology)Proliferative diabetic retinopathyTraction retinal detachment involving the macula.E11.352HighHigh risk of permanent visual loss or blindness.Vitreoretinal surgery; long-term glycemic control monitoring; intravitreal injections.
Eye (Ophthalmology)Acute angle-closure glaucomaAcute crisis; glaucomatous optic atrophy.H40.21HighIrreversible damage to optic nerve within hours.Emergency surgical intervention (iridotomy); intraocular pressure monitoring.
Eye (Ophthalmology)Corneal transplant (keratoplasty)Full thickness penetrating transplant.65730HighRisk of graft rejection or secondary glaucoma.Penetrating keratoplasty; intensive post-op drug therapy monitoring.
Eye (Ophthalmology)Glaucoma surgery complicationsBleb endophthalmitis (stage 3).H59.43HighSevere risk of permanent blindness.Intravitreal antibiotic injections and potential vitrectomy.
Eye (Ophthalmology)Neovascular Age-Related Macular Degeneration (AMD)Macular edema; classic subfoveal choroidal neovascular (CNV) lesions.67028HighHigh risk of morbidity from chronic blinding disease.Intravitreal injection (Vabysmo); Ocular Photodynamic Therapy (OPT) with verteporfin; FA/OCT monitoring.
Eye (Ophthalmology)Stevens-Johnson Syndrome (SJS)Symblepharon formation; limbal stem cell deficiency.Not in sourceHighHigh risk of permanent blindness; acute systemic threat.Systemic immunosuppressants; Amniotic Membrane Transplantation (AMT); drug therapy monitoring.
Eye (Ophthalmology)Retinal detachmentSerous, traction, or rhegmatogenous detachment.67101-67113HighPotential for permanent loss of vision.Surgical repair (cryotherapy, photocoagulation, or vitrectomy).
Eye (Ophthalmology)Ocular emergencies / Significant eye injuryAcute illness or injury posing threat to bodily function.Not in sourceHighSignificant risk of morbidity; threat to life or bodily function.Extensive evaluation to rule out or treat highly morbid conditions.
Renal/Genitourinary (Urology)Prostatectomy HemorrhagePostprocedural acute bleeding after prostate surgery.0V3HighAcute hemorrhage; hemodynamic instability.Control: Stopping or attempting to stop postprocedural bleeding.
Renal/Genitourinary (Urology)Renal Failure (End-stage)Completely taking over physiological function via extracorporeal means.5A1D, N18.6HighElectrolyte imbalance; fluid overload; mortality risk without filtration.Urinary Performance: Filtration (Hemodialysis); chronic dialysis (Z99.2).
Renal/Genitourinary (Urology)Candidal pyelonephritisCandidal sepsis; systemic candidiasis.B37.49HighRisk of renal failure and life-threatening systemic fungal infection.Systemic antifungal drug monitoring; renal function testing; surgical intervention.
Renal/Genitourinary (Urology)Sickle-cell disorderPriapism.N48.32HighRisk of permanent erectile dysfunction and tissue necrosis.Aspiration, irrigation, or surgical shunt.
Renal/Genitourinary (Urology)Radical NephrectomyMalignant neoplasm of kidney; MCC impacting MS-DRG (e.g., acute renal failure).0TT00ZZHighThreat to life or bodily function; major surgery with risk factors (advanced age, CAD, CKD).Surgical resection; removal of Gerota’s fascia; management of comorbidities.
Renal/Genitourinary (Urology)Prostate CancerMalignant neoplasm of prostate.55873HighHigh mortality without intervention.Cryosurgical ablation of the prostate and PSA monitoring.
Renal/Genitourinary (Urology)Bladder Cancer / Non-functional bladderUrinary incontinence unresponsive to treatment.0DX80ZBHighThreat to bodily function; requirement for major elective surgery.Neobladder reconstruction (Transfer of small intestine to bladder).
Renal/Genitourinary (Urology)Prostate Biopsy / Benign Prostate AblationComplex conditions requiring emerging technology.0950THighRisk of morbidity from intervention.High-Intensity Focused Ultrasound (HIFU).
Renal/Genitourinary (Urology)Testicular torsionAcute condition posing threat to bodily function.Not in sourceHighSignificant risk of morbidity; threat to life or bodily function.Extensive evaluation; surgical intervention.
Renal/Genitourinary (Urology)Kidney stone with potential complicationsAcute/chronic illness with exacerbation posing threat to life.Not in sourceHighHigh risk of morbidity without treatment.Extensive diagnostic evaluation to rule out highly morbid condition.
Renal/Genitourinary (Urology)Radical CystectomyMalnutrition / Low nutrition.Not in sourceHighWeight loss > 10%; serum albumin < 30 g/L.Nutritional Risk Screening; pre-operative nutritional supplements.
Renal/Genitourinary (Urology)Acute Renal FailureAcute/chronic illnesses posing threat to life or bodily function.Not in sourceHighHigh risk of morbidity from testing or treatment.Elective/Emergency major surgery; drug therapy requiring intensive monitoring.
Physical Medicine & Rehabilitation (PM&R)Amyotrophic lateral sclerosis (ALS)Pseudobulbar affect; respiratory failure.G12.21, F48.2Moderate to HighHigh mortality due to progressive muscle atrophy and respiratory paralysis.Respiratory support; neuromodulatory pharmacotherapy monitoring; palliative care.
Physical Medicine & Rehabilitation (PM&R)Autonomic dysreflexiaTriggered by fecal impaction or pressure ulcer in spinal cord injury.G90.4HighLife-threatening hypertension and potential stroke.Emergency removal of stimulus and blood pressure management.
Physical Medicine & Rehabilitation (PM&R)Spastic quadriplegic cerebral palsyChronic pain; significant psychosocial dysfunction; joint contractures.G80.0HighTotal loss of function; respiratory complications.Physical therapy; intensive care monitoring during exacerbations; multidisciplinary rehab.
Physical Medicine & Rehabilitation (PM&R)Chronic Pain Management / Bladder DysfunctionSevere exacerbation or threat to bodily function requiring neurostimulation.0816T-0817T, G3002, G3003Moderate to HighMorbidity from chronic functional impairment; risk of drug toxicity (e.g., lithium).Insertion of integrated neurostimulation system; monthly CPM bundle; drug therapy monitoring.
Physical Medicine & Rehabilitation (PM&R)Spinal cord lesionComplete vs. incomplete spinal cord lesion.Not in sourceHighThreat to life or bodily function; risk of permanent disability.Parenteral controlled substances; drug therapy monitoring; rehabilitation therapy.
Physical Medicine & Rehabilitation (PM&R)Progressive severe rheumatoid arthritisChronic illness with severe exacerbation or progression.Not in sourceHighHigh risk of morbidity from testing or treatment.Drug therapy requiring intensive monitoring for toxicity; de-escalation of care.
Ear, Nose, and Throat (ENT)Epistaxis (Acute bleeding)Acute bleeding of nasal mucosa and soft tissue; recurrence.093K, 30901ModerateHemorrhage; potential for airway obstruction.Cauterization; packing; drug therapy monitoring.
Ear, Nose, and Throat (ENT)Cochlear Implant TreatmentCommunication abilities/impairment; post-surgical rehabilitation needs.F0BModerate to HighSurgical recovery; sensory deficit.Application of techniques to improve communication abilities.
Ear, Nose, and Throat (ENT)Conductive Hearing LossHearing impairment requiring bone conduction fitting.09HDModerateSensory deficit; social isolation.Insertion of Hearing Device, Bone Conduction.
Ear, Nose, and Throat (ENT)Adverse effect of ENT drugsPoisoning or underdosing of ENT-specific drugs.T49.6ModerateOtitic barotrauma; damage to eardrum.Therapeutic drug level monitoring; surgical adjustment of myringotomy device.
Ear, Nose, and Throat (ENT)Sinus endoscopy with balloon dilationChronic rhinosinusitis with polyposis.31295-31297ModeratePersistent inflammation; structural obstruction.Surgical intervention (dilation); postoperative debridement (31237).
Ear, Nose, and Throat (ENT)Cochlear ImplantationBacterial Meningitis risk (Streptococcus pneumoniae).69930ModerateInner ear anatomic abnormalities.Pneumococcal vaccination at least two weeks before surgery.
Ear, Nose, and Throat (ENT)Polysomnography (PSG)Obstructive Sleep Apnea (OSA) in children.95782, 95783ModerateNeuromotor disease; Down’s syndrome; obesity; young age (<6 years).Sleep testing to determine surgical necessity for tonsillectomy.
Ear, Nose, and Throat (ENT)Post-operative nasal endoscopyComplications following nasal/sinus surgery.31237ModerateRisk of surgical site adhesion or retained debris.Debridement (limited to 3 units within six weeks post-surgery).
Ear, Nose, and Throat (ENT)Tympanostomy (In-office)Requires innovative delivery device and anesthesia.G0561, 69433ModerateIdentified patient or procedure risk factors.In-office technology resource cost capture via add-on code.
Ear, Nose, and Throat (ENT)Functional Endoscopic Sinus Surgery (FESS)Severe scarring; nasal polyps; fungal sinusitis.31254-31288ModerateFailure to respond to medical management; risks of CSF leak.Ethmoidectomy; maxillary antrostomy; computer-assisted navigation.
Ear, Nose, and Throat (ENT)Acute sialadenitis (Hospital Care)Parotiditis in a diabetic patient.99222-AIModerateType 1 diabetes mellitus with hyperglycemia.Inpatient admission; IV antibiotics; endocrinology consultation.
Ear, Nose, and Throat (ENT)Tympanoplasty with MastoidectomyEardrum perforation and mastoid disease.69644ModerateOssicular chain reconstruction.Surgical reconstruction with cartilage, bone, or synthetic materials.
Ear, Nose, and Throat (ENT)Laryngoscopy, flexible; diagnosticPersistent hoarseness in a recreational smoker.31575ModerateGag reflex preventing mirror exam.Topical anesthesia/decongestant; referral to speech therapy.
Eye (Ophthalmology)Glaucoma (Anterior Chamber)Aqueous drainage obstruction.08123, H40Moderate to HighIncreased intraocular pressure; vision loss.Bypass: Altering route of contents; diagnostic stage monitoring.
Eye (Ophthalmology)Foreign body on external eyeMechanical complication of lens; corneal transplant rejection.T15.0, T15.1, T85.2ModerateRupture and destruction of eyeball.Diagnostic testing; surgical replacement of lens; removal of device.
Eye (Ophthalmology)Diagnostic exam under anesthesiaComplete evaluation with risk factors.92018ModerateRisks of general anesthesia.Comprehensive examination under anesthesia; ophthalmoscopy.
Eye (Ophthalmology)Intravitreal injectionMacular edema; retinal detachment; wet AMD.67028Low to ModerateRisk of endophthalmitis.Injection of medication; drug therapy monitoring.
Eye (Ophthalmology)Cataract surgery with IOL insertionSignificant cataract with refractive errors.66984ModerateRisk of capsular opacification or macular edema.Extracapsular lens removal and surgical lens replacement.
Eye (Ophthalmology)Retinal disease / Computer imagingProgressive vision loss.92134ModerateIrreversible ocular damage.Scanning computerized ophthalmic diagnostic imaging; monitoring (limit 1/28 days).
Eye (Ophthalmology)Localized lesion of choroidsChoroidal lesion.67221-67225ModerateIrreversible damage.Diagnostic imaging; fluorescein angiography; Verteporfin monitoring.
Eye (Ophthalmology)B-scan UltrasoundObscured view of posterior segment.76512 or 76513ModerateIntraocular mass; retinal detachment.Standard Contact or Immersion B-scan.
Eye (Ophthalmology)KeratoconjunctivitisInflammation; visual disturbances; Shield Ulcer.H10.1-, H10.4-, B30.1Moderate to HighPotential for vision-threatening inflammation.Slit-lamp exam; fluorescein staining; topical corticosteroids; cyclosporine.
Renal/Genitourinary (Urology)Mechanical complication of urinary catheterInfection and inflammatory reaction; leakage; breakdown.T83.0, T83.51ModerateSepsis; organ dysfunction.Replacement or removal of catheter; drug therapy for infection.
Renal/Genitourinary (Urology)Gastrointestinal/Urology device complicationBreakdown or displacement of penile prosthesis; urinary stents.T83.1, T83.4, T83.6ModerateStenosis; hemorrhage; embolism.Adjustment and management of implanted devices; drug therapy monitoring.
Renal/Genitourinary (Urology)Cystourethroscopy with biopsyEndoscopic procedure with tissue sampling.52204ModerateRisk of bleeding; UTI; perforation.Cystoscopic biopsy; post-procedural drug therapy monitoring.
Renal/Genitourinary (Urology)Prostate biopsy (needle)Transrectal diagnostic sampling.55700ModerateRisk of sepsis or hematuria.Needle biopsy; prophylactic antibiotic therapy.
Renal/Genitourinary (Urology)Urologic Surgery risk factorsObstructive Sleep Apnea (OSA); Diabetes Mellitus.G47.33, E11.9Moderate to HighObesity; cardiovascular disease; HbA1c > 8%.Berlin Questionnaire; pre-operative CPAP; insulin dose management.
Renal/Genitourinary (Urology)Interstitial cystitisChronic inflammatory condition of the bladder.J1212ModerateChronic pain; bladder wall scarring.Bladder instillation (51720) using Dimethylsulfoxide (DMSO).
Renal/Genitourinary (Urology)Chronic Kidney Disease (CKD)CKD Stage 4 or 5; hypertensive kidney disease.N18.4, N18.5Moderate to HighProgression to kidney failure; comorbid diabetes.Drug therapy monitoring; possible hospitalization.
Renal/Genitourinary (Urology)Transurethral Resection of the Prostate (TURP)BPH; recurrent UTI; incomplete bladder emptying.52601, 52648, 99218-99220ModeratePost-op abdominal pain; kidney stone; delirium (Age > 70).Observation admission; management of stone; geriatric assessment.
Renal/Genitourinary (Urology)Urodynamic Studies (UDS)Neurologic conditions (Multiple Sclerosis, SCI).51728, 51729Low to ModerateRisk of recurrent UTIs.Complex cystometrograms; treatment of infection prior to testing.
Renal/Genitourinary (Urology)Gross hematuria / Elevated PSA evaluationUndiagnosed new problem with uncertain prognosis.52000ModerateHigh risk of morbidity (underlying cancer).Upper tract imaging; cystoscopy; antibiotic trial.
Renal/Genitourinary (Urology)Management of Kidney StonesUpper urinary tract stones.Not in sourceModerateRenal failure; chronic dehydration; infection.Extracorporeal Shock Wave Lithotripsy (ESWL); Percutaneous Lithotripsy.
Renal/Genitourinary (Urology)Urinary IncontinenceStress and/or urge incontinence.Not in sourceModerateFailed trial of pelvic muscle exercise (PME).Biofeedback-assisted PME training.
Physical Medicine & Rehabilitation (PM&R)Assessment of Motor/Nerve FunctionFunctional impairment requiring performance assessment.F01ModerateNeurological or musculoskeletal deficits.Measurement using orthosis or prosthesis fitting; rehabilitation assessment.
Physical Medicine & Rehabilitation (PM&R)Motor Treatment/ExerciseFunctional motor impairment.F07, 97110ModerateLoss of joint mobility; muscle atrophy.Therapeutic Exercise; balance training; drug therapy monitoring as needed.
Physical Medicine & Rehabilitation (PM&R)Orthopedic joint prosthesis complicationBroken prosthesis; dislocation; instability.T84.0, T84.5Moderate to HighTraumatic ischemia of muscle; fibrosis; thrombosis.Joint replacement surgery (aftercare); physical therapy.
Physical Medicine & Rehabilitation (PM&R)Neuromuscular junction testingMyoneural disorders.95937ModerateProgressive muscle weakness; respiratory failure risk.Drug therapy monitoring through nerve testing (limit 3 units/day).
Physical Medicine & Rehabilitation (PM&R)Rehabilitation following injury/illnessResidual neurological deficits (hemiplegia/hemiparesis).I69.351, 169.35ModerateImpaired ADLs; risk of secondary complications (pressure ulcers).Ongoing therapeutic treatment and monitoring for healing.
Physical Medicine & Rehabilitation (PM&R)Nontraumatic subarachnoid hemorrhageCognitive deficits (attention, memory) following hemorrhage.169.01ModerateSequelae of cerebrovascular disease.Management of cognitive functions and spatial neglect.
Physical Medicine & Rehabilitation (PM&R)Walking in Spinal Cord Injury (SCI)Disuse atrophy; paralysis.Not in sourceModerateRequires intact lower motor unit; need balance/standing tolerance.NMES or FES training; 32 PT sessions over 3 months.
Physical Medicine & Rehabilitation (PM&R)Gait and mobility abnormalitiesRepeated falls.R29.6ModerateParalytic or spastic gait.Stroke Scale assessment (NIHSS) if post-infarction.
Physical Medicine & Rehabilitation (PM&R)Rigid musculoskeletal immobilizationCompartment Syndrome, Pressure Ulcers, DVT.Not in sourceModeratePotentially disabling complications.Stabilize limb; monitor for swelling; padded application.
Physical Medicine & Rehabilitation (PM&R)Laceration repair / Minor procedureLidocaine toxicity / injection side effects.Not in sourceModerateIntravascular injection; seizures; arrhythmia.Prescription drug management; direct physician order for lidocaine.
Physical Medicine & Rehabilitation (PM&R)Manual therapy techniques1 or more regions, each 15 minutes.97140ModerateLow risk of morbidity from treatment.Manual therapeutic manipulation.
Physical Medicine & Rehabilitation (PM&R)Percutaneous nephrolithotomy (PCNL)Impairment in Activities of Daily Living (ADLs).Not in sourceModerateImpaired baseline functional status.Evaluation of ADLs; referral to PT and OT.
Physical Medicine & Rehabilitation (PM&R)Prehabilitation for Urologic SurgerySarcopenia and poor aerobic reserve.Not in sourceModerateFrailty; low METs (< 4).Strength and cardiopulmonary exercise protocols.
Eye (Ophthalmology)Glaucoma secondary to eye traumaMild stage.H40.30X1ModerateAge > 60; chronic lung disease; congestive heart failure.Intraoperative monitoring; assessment of cardiac/pulmonary risk.
Eye (Ophthalmology)Cataract Surgery preparationAge-related nuclear cataract.H25.10Low to ModerateMACE < 1% (Low risk category).Standard H+P; ASA Physical Classification assessment.
Ear, Nose, and Throat (ENT)Drainage of external ear abscess or hematomaSimple drainage encounter.69000LowRisk of minor surgical procedure.Incision and drainage; monitoring for infection.
Ear, Nose, and Throat (ENT)Nasopharyngoscopy with endoscopeDiagnostic endoscopic encounter.92511, 31231LowMinimal risk of mucosal irritation.Endoscopic diagnostic evaluation.
Ear, Nose, and Throat (ENT)Simple nasal cautery for epistaxisRecurring nosebleeds with minor hemorrhage.30901Straightforward to LowRisk of mucosal scarring.Chemical/electrical cauterization; drug therapy monitoring.
Ear, Nose, and Throat (ENT)Removal of impacted cerumenImpacted cerumen.69209, 69210 or G0268LowAuditory impairment; canal irritation.Diagnostic audiological function testing.
Eye (Ophthalmology)Annual comprehensive exam for CataractsGlaucoma suspect (stable low-risk).92014LowRisk of progression; cataracts affecting acuity.OCT of optic nerve; follow-up visual field and IOP check.
Eye (Ophthalmology)Fine needle aspirationWithout imaging guidance.10021, 65205LowLow risk of morbidity from procedure.Diagnostic needle aspiration; superficial surgical removal.
Renal/Genitourinary (Urology)Incision and drainage of abscessDeep tissue infection or blood accumulation.10061Low to ModerateInfection spread; delayed healing.Surgical incision; drainage; follow-up wound management.
Renal/Genitourinary (Urology)Urinary CatheterizationComplication or abnormal reaction following procedure.Y84.6Low to ModerateMisadventure during care; infection or trauma.Monitoring for reaction; sterile precautions.
Renal/Genitourinary (Urology)Change of ureter tube/stentUreteral obstruction or stent malfunction.50688LowRisk of infection or renal compromise.Surgical exchange of stent/tube.
Renal/Genitourinary (Urology)Benign Prostatic Hyperplasia (BPH)Stable chronic illness; bladder outlet obstruction.52648Low to ModerateRisk of renal impairment without treatment.Laser vaporization; prescription drug management.
Renal/Genitourinary (Urology)Vasectomy consultationPermanent change in health status.55250LowModerate risk procedure; change to fertility status.Decision-making regarding surgical intervention.
Physical Medicine & Rehabilitation (PM&R)Therapeutic exercisesStrength and range of motion management.97110Straightforward to LowLow risk; potential for physical strain or soreness.Direct one-on-one contact; functional testing.
Physical Medicine & Rehabilitation (PM&R)Neuromuscular reeducationMovement, balance, and coordination training.97112LowPotential for falls during training.Proprioceptive training and coordination exercises.
Physical Medicine & Rehabilitation (PM&R)Arthrocentesis / InjectionAcute joint effusion or severe osteoarthritis.20610Straightforward to LowRisk of iatrogenic infection or steroid complications.Aspiration of fluid; therapeutic drug injection.
Physical Medicine & Rehabilitation (PM&R)Diabetic Foot Ulcer / Wound CareCongestive heart failure; bone exposure.99221 or 99231Low to StraightforwardMinimal risk; no purulence.Offloading recommendations; C-reactive protein/MRI order.
Physical Medicine & Rehabilitation (PM&R)Musculoskeletal injury / Simple sprainStable acute illness.99213LowLow risk of morbidity; full recovery expected.Physical or Occupational Therapy; prescription drug management.
Ear, Nose, and Throat (ENT)Nasal packing removalRemoval following treatment.Not in sourceMinimalMinimal risk of morbidity.Aseptic technique; follow-up care.

🎯 Quick Reference: MS-DRG Decision Tree

graph LR
    A[Start: Inpatient Claim] --> B{Principal Diagnosis Valid?}
    B -->|No | C[Query Provider / MCE Reject]
    B -->|Yes | D[Assign to MDC]
    D --> E{Pre-MDC Condition?<br>Trach/ECMO/Transplant}
    E -->|Yes | F[Assign Pre-MDC DRG 001-019]
    E -->|No | G{OR Procedure Present?}
    G -->|Yes | H[Assign Surgical DRG in MDC]
    G -->|No | I[Assign Medical DRG in MDC]
    H & I --> J{Secondary Dx = MCC?}
    J -->|Yes | K[DRG with MCC]
    J -->|No | L{Secondary Dx = CC?}
    L -->|Yes | M[DRG with CC]
    L -->|No | N[DRG without CC/MCC]
    K & M & N --> O{POA=N + HAC List?}
    O -->|Yes | P[No CC/MCC Payment Adjustment]
    O -->|No | Q[Apply Full CC/MCC Weight]
    P & Q --> R[Calculate Payment:<br>Base Rate Γ— Weight Γ— Wage Index + Adjustments]
    R --> S[Submit Claim]

Bottom Line

The MS-DRG system rewards accurate, specific, clinically validated documentation. Mastery requires:
1️⃣ Understanding grouper logic flow (MDC β†’ surgical/medical β†’ CC/MCC)
2️⃣ Applying ICD-10-CM guidelines for diagnosis specificity
3️⃣ Integrating POA/HAC logic for payment integrity
4️⃣ Querying proactively when documentation lacks clinical support

When documentation aligns with clinical reality and coding rules, MS-DRG assignment follows naturallyβ€”and reimbursement reflects the true complexity of care.


Last synced: $(date)
Next review: FY 2026 IPPS Proposed Rule (expected July 2025)
Vault Status: βœ… Integrated with CMS MS-DRG Definitions Manual v42.0 and MCC Checklist